|
Sign In to gain access to subscriptions and/or personal tools.
|
Associations Between Statin Treatment and Markers of Inflammation, Vasoconstriction, and Coagulation in Patients With Abdominal Aortic Aneurysm
Anders Gottsäter, MD, PhD*,
Despina Flondell-Sité, MD,
Tilo Kölbel, MD, PhD,
and
Bengt Lindblad, MD, PhD
* To whom correspondence should be addressed. E-mail: anders.gottsater{at}med.lu.se.
 |
Abstract |
|---|
The association of statins with markers of inflammation, vasoconstriction, and coagulation was evaluated in 325 patients with abdominal aortic aneurysm with respect to statin treatment or not. Variables evaluated included routine laboratory markers, lipids, homocysteine, endothelin-1, matrix metalloproteinases (MMP)-2 and -9, and activated protein C-protein C inhibitor (APC-PCI) complex. Statin-treated patients were more often male (85% vs 75%; P = .024) and had ischemic heart disease (57% vs 19%; P < .0001). They showed lower levels of cholesterol (P< .0001), homocysteine (P = .027), MMP-9 (P = .038), and endothelin-1 (P = .005),and higher levels of APC-PCI complex (P = .042). Differences persisted in logistic regression for cholesterol (P < .0001), APC-PCI complex (P = .034), and homocysteine (P = .021). Statin-treated patients with abdominal aortic aneurysm show higher APC-PCI complex and lower homocysteine levels. Whether this translates into lower risk for aneurysm expansion or rupture will be evident from further follow-up.
First published on July 11, 2008, doi:10.1177/1538574408320027
Vascular and Endovascular Surgery 2009;42:567.
A more recent version of this article appeared on January 1, 2009

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
|
|